DE68918852D1 - Makrocylische aminophosphonsäurekomplexe, verfahren zur herstellung und formulierungen sowie verwendung. - Google Patents

Makrocylische aminophosphonsäurekomplexe, verfahren zur herstellung und formulierungen sowie verwendung.

Info

Publication number
DE68918852D1
DE68918852D1 DE68918852T DE68918852T DE68918852D1 DE 68918852 D1 DE68918852 D1 DE 68918852D1 DE 68918852 T DE68918852 T DE 68918852T DE 68918852 T DE68918852 T DE 68918852T DE 68918852 D1 DE68918852 D1 DE 68918852D1
Authority
DE
Germany
Prior art keywords
macrocylic
formulations
production
acid complexes
aminophosphonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68918852T
Other languages
English (en)
Other versions
DE68918852T2 (de
Inventor
Jaime Simon
David Wilson
Joseph Garlich
David Troutner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Application granted granted Critical
Publication of DE68918852D1 publication Critical patent/DE68918852D1/de
Publication of DE68918852T2 publication Critical patent/DE68918852T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3817—Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/06—Chelate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE68918852T 1988-12-19 1989-12-15 Makrocylische aminophosphonsäurekomplexe, verfahren zur herstellung und formulierungen sowie verwendung. Expired - Lifetime DE68918852T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/284,876 US5059412A (en) 1984-06-04 1988-12-19 Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
PCT/US1989/005782 WO1990006776A1 (en) 1988-12-19 1989-12-15 Macrocyclic aminophosphonic acid complexes, their preparation, formulations and use

Publications (2)

Publication Number Publication Date
DE68918852D1 true DE68918852D1 (de) 1994-11-17
DE68918852T2 DE68918852T2 (de) 1995-05-11

Family

ID=23091854

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68918852T Expired - Lifetime DE68918852T2 (de) 1988-12-19 1989-12-15 Makrocylische aminophosphonsäurekomplexe, verfahren zur herstellung und formulierungen sowie verwendung.

Country Status (26)

Country Link
US (1) US5059412A (de)
EP (2) EP0408701B1 (de)
JP (1) JP2515929B2 (de)
KR (1) KR0178966B1 (de)
CN (1) CN1025983C (de)
AR (1) AR248140A1 (de)
AT (1) ATE112689T1 (de)
AU (3) AU639899B2 (de)
BR (1) BR8907255A (de)
CA (1) CA2005880C (de)
CY (1) CY1902A (de)
DE (1) DE68918852T2 (de)
DK (1) DK175479B1 (de)
ES (1) ES2061010T3 (de)
FI (1) FI101857B1 (de)
HK (1) HK146795A (de)
HU (1) HU207454B (de)
IE (2) IE66391B1 (de)
IL (1) IL92784A (de)
MX (1) MX18786A (de)
NO (1) NO180434C (de)
NZ (1) NZ231818A (de)
PT (1) PT92619B (de)
SA (1) SA91120234B1 (de)
WO (1) WO1990006776A1 (de)
ZA (1) ZA899734B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US5645818A (en) * 1989-03-24 1997-07-08 Guerbet S.A. Diagnostic compositions comprising a complex formed by a nitrogenous macrocyclic ligand with metal ions
DE4009119A1 (de) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
WO1991016075A1 (en) * 1990-04-20 1991-10-31 Australian Nuclear Science & Technology Organisation Bone marrow treatments
MC2260A1 (fr) * 1990-06-18 1993-04-26 Dow Chemical Co Formulations de produits radiopharmaceutiques,leur methode d'administration et leur procede de preparation
HU211735B (en) * 1990-06-18 1995-12-28 Dow Chemical Co Method for obtaining macrocyclic amino-phosphonic acid complexes
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5320829A (en) * 1991-12-10 1994-06-14 The Dow Chemical Company Oral compositions for inhibiting plaque formation
US5428139A (en) * 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
US5739294A (en) * 1991-12-10 1998-04-14 The Dow Chemical Company Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
AU703340B2 (en) * 1995-06-26 1999-03-25 Chelator Llc Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
JP2003501488A (ja) * 1999-06-11 2003-01-14 ネオルックス コーポレイション 骨髄抑制のための高投与量放射性核種錯体
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6565828B2 (en) * 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
AU2002249935A1 (en) * 2001-01-08 2002-08-19 Neorx Corporation Radioactively labelled conjugates of phosphonates
WO2002055112A2 (en) * 2001-01-09 2002-07-18 Bristol Myers Squibb Co Polypodal chelants for metallopharmaceuticals
US7045116B2 (en) 2001-12-13 2006-05-16 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
US20030228256A1 (en) * 2002-06-11 2003-12-11 Inverardi Luca A. Methods of achieving transplantation tolerance through radioablation of hemolymphopoietic cell populations
WO2007008232A2 (en) 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
WO2011149844A1 (en) * 2010-05-24 2011-12-01 Iso Therapeutics Group Llc Delivery of high dose therapeutic radioisotopes to bone
PT3054996T (pt) 2013-10-07 2023-08-01 Igl Pharma Inc Processo para preparar agentes ósseos terapêuticos de alta pureza
WO2016191413A1 (en) 2015-05-25 2016-12-01 Iso Therapeutics Group, Llc Dotmp kit formulations for radioisotopes
US11369700B2 (en) 2015-05-25 2022-06-28 IGL Pharma Inc. DOTMP kit formulations for radioisotopes
PL3519394T3 (pl) 2016-09-27 2020-11-30 Bayer Pharma Aktiengesellschaft Sposób wytwarzania krystalicznej postaci o modyfikacji a kalkobutrolu
WO2018148209A1 (en) 2017-02-08 2018-08-16 Iso Therapeutics Group, Llc Method of use for therapeutic bone agents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965254A (en) * 1973-05-23 1976-06-22 The Procter & Gamble Company Compositions for the treatment of calcific tumors
US4017595A (en) * 1975-08-28 1977-04-12 Research Corporation Bone-seeking indium-113m or indium-111 organic phosphonate complexes
CA1078731A (en) * 1976-12-16 1980-06-03 Charles E. Frosst And Co. Skeletal imaging kit utilizing triethylene tetramine hexa (methylene phosphonic acid)
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
SU1098937A1 (ru) * 1983-03-25 1984-06-23 Ордена Ленина институт элементоорганических соединений им.А.Н.Несмеянова 1,4,7,10-Тетра/диоксифосфорилметил/-1,4,7,10-тетраазациклододекан в качестве комплексона дл св зывани катионов меди /п/,кобальта /п/,кадми /п/,свинца /п/ и лантана /ш/
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US5064633A (en) * 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
AU563671B2 (en) * 1984-06-04 1987-07-16 Dow Chemical Company, The Organic amine phosphonic acid complexes
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
FR2614020B1 (fr) * 1987-04-14 1989-07-28 Guerbet Sa Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.
US4853209A (en) * 1987-05-18 1989-08-01 The Dow Chemical Company Bone marrow suppressing agents
US4882142A (en) * 1988-12-19 1989-11-21 The Dow Chemical Company Bone marrow suppressing agents
US4976950A (en) * 1988-12-19 1990-12-11 The Dow Chemical Company Bone marrow suppressing agents

Also Published As

Publication number Publication date
HK146795A (en) 1995-09-22
EP0408701A1 (de) 1991-01-23
FI101857B (fi) 1998-09-15
PT92619B (pt) 1995-09-12
CN1046739A (zh) 1990-11-07
FI101857B1 (fi) 1998-09-15
CN1025983C (zh) 1994-09-28
MX18786A (es) 1993-12-01
EP0408701B1 (de) 1994-10-12
KR0178966B1 (ko) 1999-03-20
BR8907255A (pt) 1991-03-12
KR910700073A (ko) 1991-03-13
ZA899734B (en) 1991-08-28
EP0408701A4 (en) 1991-07-31
NO180434C (no) 1997-04-23
US5059412A (en) 1991-10-22
IE940833L (en) 1990-06-19
AU5068593A (en) 1994-02-24
HU901163D0 (en) 1991-03-28
CY1902A (en) 1989-12-15
IE894063L (en) 1990-06-19
WO1990006776A1 (en) 1990-06-28
JP2515929B2 (ja) 1996-07-10
AU657641B2 (en) 1995-03-16
DK195990D0 (da) 1990-08-16
DK195990A (da) 1990-08-16
ES2061010T3 (es) 1994-12-01
IL92784A (en) 1994-08-26
HUT54897A (en) 1991-04-29
CA2005880A1 (en) 1990-06-19
NO180434B (no) 1997-01-13
JPH03502936A (ja) 1991-07-04
PT92619A (pt) 1990-06-29
AU639899B2 (en) 1993-08-12
AU4828290A (en) 1990-07-10
AU4700989A (en) 1990-06-21
SA91120234B1 (ar) 2004-09-04
CA2005880C (en) 1999-01-05
NZ231818A (en) 1992-05-26
IL92784A0 (en) 1990-09-17
IE66391B1 (en) 1995-12-27
EP0375376A2 (de) 1990-06-27
HU207454B (en) 1993-04-28
AR248140A1 (es) 1995-06-30
NO903632D0 (no) 1990-08-17
EP0375376A3 (de) 1991-06-12
ATE112689T1 (de) 1994-10-15
NO903632L (no) 1990-10-17
DE68918852T2 (de) 1995-05-11
DK175479B1 (da) 2004-11-08
FI904084A0 (fi) 1990-08-17

Similar Documents

Publication Publication Date Title
DE68918852T2 (de) Makrocylische aminophosphonsäurekomplexe, verfahren zur herstellung und formulierungen sowie verwendung.
DE3766878D1 (de) Prothesenteil sowie verfahren zu seiner herstellung.
DE3876166T2 (de) Sekundaerbatterie und verfahren zur herstellung derselben.
DE3582754D1 (de) Medizinisches werkzeug und verfahren zur herstellung.
DE3769174D1 (de) Indolizin-derivate, verfahren zur herstellung und diese enthaltende zusammensetzungen.
DE3674752D1 (de) Alpha, alpha-trehalose-derivat und verfahren zur herstellung davon.
DE3782994D1 (de) Erythromycin-a-derivate und verfahren zu ihrer herstellung.
DE3582110D1 (de) Verdickungsmittel, verfahren zur herstellung und ihre verwendung.
DE3878475D1 (de) Organopolysiloxanemulsion und verfahren zu ihrer herstellung.
DE68917457D1 (de) Deodorant und verfahren zur herstellung.
DE3575071D1 (de) Epipodophyllotoxinchinon-glukosid-abkoemmlinge, verfahren zur herstellung und verwendung.
DE69102275D1 (de) Alumina enthaltende säureadsorbentien und verfahren zur herstellung derselben.
DE3482258D1 (de) 2,2-difluorpropionsaeurederivate und verfahren zu ihrer herstellung.
DE3886936T2 (de) 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG.
DE3880287D1 (de) Chlortrifluoraethylen-telomere und verfahren zu ihrer herstellung.
DE3765855D1 (de) Dimethylphenylsilylmethylpolysilan und verfahren zur herstellung desselben.
DE3868905D1 (de) Verschleissteil und verfahren zu seiner herstellung.
DE3778517D1 (de) 7-brom-beta-carbolin-derivate und verfahren zu ihrer herstellung.
DE3783815D1 (de) Poly 1,2,2-trimethyl-1-phenyldisilane und verfahren zur herstellung.
DE3761140D1 (de) Phosphorsaeureester und verfahren zu ihrer herstellung.
DE3768416D1 (de) Iminooxazolidine, verfahren zu ihrer herstellung und ihre verwendung.
DE3851541D1 (de) Propylen-äthylen-kopolymer-zusammensetzung und verfahren zur herstellung.
DE3578884D1 (de) Chinoloncarbonsaeure derivate und verfahren zu ihrer herstellung.
AT388293B (de) Stabiles, zahnbelag verhinderndes zahnpflegemittel und verfahren zur herstellung desselben
DE3485988T2 (de) Cinnamoylverbindungen, verfahren zur herstellung und ihre verwendung als heilmittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition